Uncategorized

Eli Lilly first linked up with Gate Bioscience in July 2025 to leverage the biotech’s “Molecular Gate” engine to treat diseases with high unmet need. Monday’s expansion will add one undisclosed target to the existing agreement, with an option for a second.

About 20.8 million Medicare beneficiaries will receive a $90 direct deposit or check this month, the latest in a growing list of cash payments promised by the White House in advance of the November midterm elections

VAX-31 beat Pfizer and Merck’s established pneumococcal conjugate vaccines in a Phase 3 trial, exceeding investors’ most ambitious scenario and setting Vaxcyte up to challenge the Big Pharmas in a market worth $8 billion.

All signs continue to point forward for Biogen’s initial foray into lupus, as litifilimab elicited clear or almost clear skin within one year in patients with cutaneous lupus in a mid-stage study. Data from two Phase 3 studies of systemic lupus are expected by the end of the year.

CSL will co-develop and co-promote Alentis Therapeutics’ anti-claudin-1 therapy lixudebart for kidney and liver conditions, including primary sclerosing cholangitis and a systemic autoimmune disease characterized by small blood vessel inflammation.

Not a month after reports of three deaths in autoimmune trials for Novartis’ CAR T cell therapy ignited a debate about the use of these treatments in nonfatal diseases, Kyverna Therapeutics reported data bolstering its case to bring to market the first CAR T for an autoimmune disease.

En la década de 1930, la biología era una ciencia eminentemente descriptiva. Se analizaban órganos, se clasificaban especies y se observaban células al microscopio, pero el mecanismo íntimo de la herencia genética continuaba siendo un enigma envuelto en penu …

The health insurance industry does not simply need another point solution. It needs the connective tissue that allows existing investments to collaborate.

Thermo Fisher turned fragmented KOL data into real-time market demand. Read how.

Patient access problems often start with fragmented workflows, not staffing alone.